StockMarketWire.com - UK healthcare company Concepta said Tuesday it had agreed to supply its fertility and hormone self-test platform product to Walgreens Boots Alliance.

The supply agreement represented the first commercial partnership and formed part of the company's EU roll-out plans.

The company's self-test platform MyLotus recently received CE-Mark certification and the agreement would allow the company to extend its UK relationship with 'Boots the Chemist' to other Walgreens Boots Alliance partners across EU markets.


At 9:52am: [LON:CPT] Concepta Plc share price was +0.2p at 4p



Story provided by StockMarketWire.com